Xtant Medical Holdings Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scroll to see more
Xtant Medical Holdings, Inc. income statement - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
Revenue & Gross Profit
Revenue117.2791.3057.9755.2653.3464.68
Cost of Revenue49.0535.8425.8322.7718.95-22.17
Gross Profit68.2255.4732.1432.4934.3942.52
Operating Expenses
Research & Development2.391.340.920.870.660.93
Selling, General & Administrative77.9164.2937.9834.8734.4943.84
Operating Expenses80.2965.6338.8935.7435.14-44.77
Operating Income-12.07-10.16-6.76-3.25-0.75-2.42
Other Income/Expense
Interest Income0.000.150.030.000.000.00
Interest Expense-4.16-2.941.69-1.00-5.980.00
Other Income/Expense-0.03-0.05-139.41-0.12-0.15-0.07
Income
Income Before Tax-16.26-1.04-8.42-4.85-6.73-8.12
Income Tax Expense0.19-1.700.07-0.110.300.10
Net Income-16.450.66-8.49-4.85-7.02-8.22
Net Income - Continuous Operations-16.450.66-8.49-4.850.000.00
Net Income - Discontinued Operations0.000.000.000.000.000.00
EBITDA-7.85-6.98-5.43-1.921.330.74
EBIT-12.07-10.16-6.72-3.25-0.75-2.40
Depreciation & Amortization4.223.171.291.332.08-3.10
Earnings Per Share
Basic EPS------1.00
Diluted EPS------1.00
Basic Shares Outstanding133.67119.0994.0985.4628.5013.16
Diluted Shares Outstanding133.67126.7994.0985.4628.5013.16